Linalool modulates dermatophyte susceptibility to azole drugs.
暂无分享,去创建一个
[1] S. Sampson,et al. Small Molecule Efflux Pump Inhibitors in Mycobacterium tuberculosis: A Rational Drug Design Perspective. , 2017, Mini reviews in medicinal chemistry.
[2] M. Morais-Braga,et al. Inhibition of the TetK efflux-pump by the essential oil of Chenopodium ambrosioides L. and α-terpinene against Staphylococcus aureus IS-58. , 2017, Food and chemical toxicology : an international journal published for the British Industrial Biological Research Association.
[3] P. Magin,et al. Oral antifungal medication for toenail onychomycosis. , 2017, The Cochrane database of systematic reviews.
[4] G. M. Chaves,et al. Epidemiology and fungal species distribution of superficial mycoses in Northeast Brazil. , 2017, Journal de mycologie medicale.
[5] L. Salgueiro,et al. Natural Products: An Alternative to Conventional Therapy for Dermatophytosis? , 2016, Mycopathologia.
[6] H. Coutinho,et al. Inhibition of the NorA efflux pump of Staphylococcus aureus by synthetic riparins , 2016, Journal of applied microbiology.
[7] A. Franceschini,et al. Compensatory expression of multidrug-resistance genes encoding ABC transporters in dermatophytes. , 2016, Journal of medical microbiology.
[8] M. Ghannoum. Azole Resistance in Dermatophytes: Prevalence and Mechanism of Action. , 2015, Journal of the American Podiatric Medical Association.
[9] P. Calow,et al. RIFM fragrance ingredient safety assessment, Linalool, CAS registry number 78-70-6. , 2015, Food and chemical toxicology : an international journal published for the British Industrial Biological Research Association.
[10] L. Kubena,et al. Evaluation of linalool, a natural antimicrobial and insecticidal essential oil from basil: effects on poultry. , 2014, Poultry science.
[11] L. Amaral,et al. Inhibitors of mycobacterial efflux pumps as potential boosters for anti-tubercular drugs , 2012, Expert review of anti-infective therapy.
[12] Po Ughachukwu,et al. Efflux Pump-Mediated Resistance in Chemotherapy , 2012, Annals of medical and health sciences research.
[13] Iri,et al. ANTIFUNGAL ACTIVITY OF THE ESSENTIAL OILS AND COMPONENTS IN VITRO AND IN VIVO ON EXPERIMENTALLY INDUCED DERMATOMYCOSES AT RATS , 2012 .
[14] C. Vágvölgyi,et al. In vitro antifungal activity of phenothiazines and their combination with amphotericin B against different Candida species , 2011, Mycoses.
[15] F. C. A. Maranhão,et al. Dermatófitos: interação patógeno-hospedeiro e resistência a antifúngicos , 2010 .
[16] H. Coutinho,et al. Enhancement of the Antibiotic Activity against a Multiresistant Escherichia coli by Mentha arvensis L. and Chlorpromazine , 2008, Chemotherapy.
[17] F Bakkali,et al. Biological effects of essential oils--a review. , 2008, Food and chemical toxicology : an international journal published for the British Industrial Biological Research Association.
[18] D. A. Santos,et al. In vitro methods for antifungal susceptibility testing of Trichophyton spp. , 2006, Mycological research.
[19] W. Maccheroni,et al. Role of the ABC transporter TruMDR2 in terbinafine, 4-nitroquinoline N-oxide and ethidium bromide susceptibility in Trichophyton rubrum. , 2006, Journal of medical microbiology.
[20] M. Klepser,et al. Comparison of Etest, chequerboard dilution and time-kill studies for the detection of synergy or antagonism between antifungal agents tested against Candida species. , 2002, The Journal of antimicrobial chemotherapy.